Search
for
Sort by
Research 31–60 of 87
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Momentary fluke of cyclosporine in incidental repigmentation and hypertrichosis of hair
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Epigenetics of Colorectal Cancer
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Macrophages induce AKT/β-catenin-dependent Lgr5+ stem cell activation and hair follicle regeneration through TNF
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- PROTACs: A novel strategy for cancer drug discovery and development
- How drug repurposing can advance drug discovery: challenges and opportunities
- Changing Incidence Trends of Cutaneous B-Cell Lymphoma
- A review of cutaneous lupus erythematosus: improving outcomes with a multidisciplinary approach
- Bendamustine in Indolent Non-Hodgkin's Lymphoma: A Practice Guide for Patient Management
- Human Hair Graying Revisited: Principles, Misconceptions, and Key Research Frontiers
- British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Hair repigmentation associated with the use of brentuximab
- Design, Synthesis, and Optimization of Silver Nanoparticles Using an<i>Artocarpus heterophyllus</i>Lam. Leaf Extract and Its Antibacterial Application
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Sorafenib stimulates human skin type mast cell degranulation and maturation
- Tumid Lupus Erythematosus and Systemic Lupus Erythematosus: A Report on Their Rare Coexistence
- Advancing Design Strategy of PROTACs for Cancer Therapy
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Hair follicle-derived melanocyte transplant as a promising treatment strategy for vitiligo
- Premature hair graying: a multifaceted phenomenon
- Drug-induced hair pigmentation: Clinical perspectives and updates